Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN

Overview | Financials
Company Name Day One Biopharmaceuticals, Inc.
Symbol DAWN
Currency USD
Price 14.13
Market Cap 1,240,055,865
Dividend Yield 0%
52-week-range 9.67 - 18.07
Industry Biotechnology
Sector Healthcare
CEO Dr. Jeremy Bender M.B.A., Ph.D.
Website https://dayonebio.com

An error occurred while fetching data.

About Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The

Related Stocks

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

2.34 USD

CareMax, Inc. logo

CareMax, Inc.

CMAX

2.04 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

1.13 USD

Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

BNGO

0.43 USD

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

59.88 USD

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

1.49 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

37.51 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

3.6 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.987 USD

Financials

Numbers are in millions USD

Numbers are in millions USD